NYSE:DPLO - Diplomat Pharmacy Stock Price, News, & Analysis

Diplomat Pharmacy trades on the New York Stock Exchange (NYSE) under the ticker symbol "DPLO."

Diplomat Pharmacy Inc (NYSE:DPLO) released its earnings results on Tuesday, November, 6th. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.22 by $0.21. The company had revenue of $1.37 billion for the quarter, compared to analysts' expectations of $1.42 billion. Diplomat Pharmacy had a return on equity of 5.31% and a net margin of 0.04%. The firm's revenue for the quarter was up 22.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.01 EPS. View Diplomat Pharmacy's Earnings History.

Diplomat Pharmacy is scheduled to release their next quarterly earnings announcement on Monday, February 25th 2019. View Earnings Estimates for Diplomat Pharmacy.

Diplomat Pharmacy updated its FY 2018 earnings guidance on Monday, January, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $5.5-5.6 billion, compared to the consensus revenue estimate of $5.56 billion.

12 equities research analysts have issued twelve-month price targets for Diplomat Pharmacy's shares. Their predictions range from $15.00 to $33.00. On average, they expect Diplomat Pharmacy's stock price to reach $22.70 in the next year. This suggests a possible upside of 70.0% from the stock's current price. View Analyst Price Targets for Diplomat Pharmacy.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Diplomat Pharmacy in the last year. There are currently 7 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Diplomat Pharmacy.

Media stories about DPLO stock have trended somewhat negative recently, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Diplomat Pharmacy earned a daily sentiment score of -1.2 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the next few days.

Some companies that are related to Diplomat Pharmacy include Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Diplomat Pharmacy's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Louisiana State Employees Retirement System (0.03%) and Fox Run Management L.L.C. (0.02%). Company insiders that own Diplomat Pharmacy stock include Atul Kavthekar, Jeffrey G Park, Joel Saban, Philip R Hagerman and Shawn Tomasello. View Institutional Ownership Trends for Diplomat Pharmacy.

DPLO stock was sold by a variety of institutional investors in the last quarter, including Louisiana State Employees Retirement System. Company insiders that have sold Diplomat Pharmacy company stock in the last year include Jeffrey G Park, Philip R Hagerman and Shawn Tomasello. View Insider Buying and Selling for Diplomat Pharmacy.

DPLO stock was acquired by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C.. Company insiders that have bought Diplomat Pharmacy stock in the last two years include Atul Kavthekar, Jeffrey G Park and Joel Saban. View Insider Buying and Selling for Diplomat Pharmacy.

Shares of DPLO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of DPLO stock can currently be purchased for approximately $13.35.

Diplomat Pharmacy has a market capitalization of $975.62 million and generates $4.49 billion in revenue each year. The company earns $15.51 million in net income (profit) each year or $0.84 on an earnings per share basis. Diplomat Pharmacy employs 2,419 workers across the globe.

The official website for Diplomat Pharmacy is http://www.diplomatpharmacy.com.

Diplomat Pharmacy's mailing address is 4100 S. SAGINAW ST., FLINT MI, 48507. The company can be reached via phone at 888-720-4450 or via email at [email protected]